EGLN Inhibition Enables Dose-Escalated Radiation and Improves Survival Through Reduced GI Toxicity and Reduced Micrometastases

Authors :: Amit Deorukhkar
Lauren E. Colbert
Y. Huang
L. Baseler
Cullen M. Taniguchi
Tara N. Fujimoto
Jessica M. Molkentine
Source :: International Journal of Radiation Oncology*Biology*Physics. 99:E619-E620
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Pathology
Radiation
business.industry
Internal medicine
Toxicity
medicine
Radiology, Nuclear Medicine and imaging
business

Full Text Access

Tools